2 - 4ĪDL can be divided into basic ADL (BADL) and instrumental ADL (IADL).
Along with cognitive measures, ADL measures are commonly included in clinical trials of anti-dementia drugs as a primary outcome measure. ADL assessment is also an important outcome measure in evaluating efficacy of anti-dementia drugs. Patients or their families complain about forgetting appointments, difficulties in managing money or dressing themselves, inability to use telephone and so on.
Impaired ADL can be disclosed by clinical interviews. 1 Functional assessment instruments measure activities of daily living (ADL), a measure of a person's ability to live independently. The decline of functional activities is the critical feature in the diagnosis of dementia.
